SARS-CoV-2 productively infects human gut enterocytes
- PMID: 32358202
- PMCID: PMC7199907
- DOI: 10.1126/science.abc1669
SARS-CoV-2 productively infects human gut enterocytes
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause coronavirus disease 2019 (COVID-19), an influenza-like disease that is primarily thought to infect the lungs with transmission through the respiratory route. However, clinical evidence suggests that the intestine may present another viral target organ. Indeed, the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) is highly expressed on differentiated enterocytes. In human small intestinal organoids (hSIOs), enterocytes were readily infected by SARS-CoV and SARS-CoV-2, as demonstrated by confocal and electron microscopy. Enterocytes produced infectious viral particles, whereas messenger RNA expression analysis of hSIOs revealed induction of a generic viral response program. Therefore, the intestinal epithelium supports SARS-CoV-2 replication, and hSIOs serve as an experimental model for coronavirus infection and biology.
Copyright © 2020, American Association for the Advancement of Science.
Figures
Comment in
-
Organoids demonstrate gut infection by SARS-CoV-2.Nat Rev Gastroenterol Hepatol. 2020 Jul;17(7):383. doi: 10.1038/s41575-020-0317-5. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32427981 Free PMC article. No abstract available.
-
Novel Coronavirus Disease-2019 and the Gastrointestinal Tract: Lessons Learned from Human Organoids.Gastroenterology. 2020 Dec;159(6):2245-2247. doi: 10.1053/j.gastro.2020.09.039. Epub 2020 Oct 1. Gastroenterology. 2020. PMID: 33010249 Free PMC article. No abstract available.
-
The mini lungs and other organoids helping to beat COVID.Nature. 2021 May;593(7860):492-494. doi: 10.1038/d41586-021-01395-z. Nature. 2021. PMID: 34040221 No abstract available.
References
-
- Drosten C., Günther S., Preiser W., van der Werf S., Brodt H.-R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R. A. M., Berger A., Burguière A.-M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.-C., Müller S., Rickerts V., Stürmer M., Vieth S., Klenk H.-D., Osterhaus A. D. M. E., Schmitz H., Doerr H. W., Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967–1976 (2003). 10.1056/NEJMoa030747 - DOI - PubMed
-
- Guan W. J., Ni Z. Y., Hu Y., Liang W. H., Ou C. Q., He J. X., Liu L., Shan H., Lei C. L., Hui D. S. C., Du B., Li L. J., Zeng G., Yuen K.-Y., Chen R. C., Tang C. L., Wang T., Chen P. Y., Xiang J., Li S. Y., Wang J. L., Liang Z. J., Peng Y. X., Wei L., Liu Y., Hu Y. H., Peng P., Wang J. M., Liu J. Y., Chen Z., Li G., Zheng Z. J., Qiu S. Q., Luo J., Ye C. J., Zhu S. Y., Zhong N. S.; China Medical Treatment Expert Group for Covid-19 , Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020). 10.1056/NEJMoa2002032 - DOI - PMC - PubMed
-
- Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G. F., Tan W.; China Novel Coronavirus Investigating and Research Team , A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020). 10.1056/NEJMoa2001017 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
